Cholesterol crystal embolisation to the alimentary tract

Area of Science:

• Gastroenterology
• Pathology
• Cardiovascular Disease

Background:

• Cholesterol crystal embolisation (CCE) is a complication of atherosclerotic disease.
• CCE can affect various organs, including the gastrointestinal tract.

Purpose of the Study:

• To investigate the clinical and pathological features of CCE in the alimentary tract.
• To determine the frequency and location of CCE in the gastrointestinal system.
• To analyze diagnostic challenges and outcomes associated with CCE.

Main Methods:

• Retrospective analysis of clinical and pathological data.
• Inclusion of 96 patients diagnosed with CCE from a national pathology database (1973-1992).
• Review of 130 CCE sites across the alimentary tract.

Main Results:

• CCE most commonly occurred in the colon (42.3%).
• Presenting symptoms included abdominal pain, diarrhea, and gastrointestinal bleeding.
• CCE was often misdiagnosed, with ischemic colitis, tumors, or inflammatory bowel disease considered.
• A premortem diagnosis was made in 70.8% of cases.
• CCE was linked to mortality in 24 of 35 necropsy examinations.

Conclusions:

• Cholesterol crystal embolisation (CCE) predominantly affects the colon.
• CCE presents with symptoms that mimic other gastrointestinal disorders, complicating diagnosis.
• Timely diagnosis of CCE is crucial, especially in patients with a history of atherosclerotic disease.